{'52WeekChange': 0.056674004,
 'SandP52WeekChange': 0.0644362,
 'address1': 'Delaware Corporate Center II',
 'address2': 'Suite 200 2 Righter Parkway',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 62.62,
 'askSize': 1100,
 'averageDailyVolume10Day': 28837,
 'averageVolume': 37176,
 'averageVolume10days': 28837,
 'beta': 0.897478,
 'beta3Year': None,
 'bid': 60,
 'bidSize': 900,
 'bookValue': 17.618,
 'category': None,
 'circulatingSupply': None,
 'city': 'Wilmington',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 63.8899,
 'dayLow': 62.17,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': 0.019,
 'enterpriseToEbitda': 11.906,
 'enterpriseToRevenue': 8.916,
 'enterpriseValue': 354210336,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 62.769714,
 'fiftyTwoWeekHigh': 69.51,
 'fiftyTwoWeekLow': 42,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 4307170,
 'forwardEps': 5.75,
 'forwardPE': 10.862609,
 'fromCurrency': None,
 'fullTimeEmployees': 7,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.2615,
 'heldPercentInstitutions': 0.66743,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 703814400,
 'lastSplitFactor': '2:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/biospecifics.com',
 'longBusinessSummary': 'BioSpecifics Technologies Corp., a biopharmaceutical '
                        'company, develops an injectable collagenase '
                        'clostridium histolyticum for various indications in '
                        'the United States and internationally. The company '
                        'offers injectable collagenase for the treatment of '
                        "Dupuytren's contracture and Peyronie's disease under "
                        'the XIAFLEX and Xiapex brands. It also provides '
                        'injectable collagenase to treat frozen shoulder, '
                        'cellulite, canine lipoma, lateral hip fat, plantar '
                        'fibromatosis, human lipoma, and uterine fibroids. The '
                        'company has a development and license agreement with '
                        'Endo Global Ventures. BioSpecifics Technologies Corp. '
                        'was founded in 1957 and is headquartered in '
                        'Wilmington, Delaware.',
 'longName': 'BioSpecifics Technologies Corp.',
 'market': 'us_market',
 'marketCap': 458766208,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_352160',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 24552020,
 'nextFiscalYearEnd': 1640908800,
 'open': 62.98,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 1.41,
 'phone': '302-842-8450',
 'previousClose': 63.39,
 'priceHint': 2,
 'priceToBook': 3.5452378,
 'priceToSalesTrailing12Months': 11.547889,
 'profitMargins': 0.61801,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 63.8899,
 'regularMarketDayLow': 62.17,
 'regularMarketOpen': 62.98,
 'regularMarketPreviousClose': 63.39,
 'regularMarketPrice': 62.98,
 'regularMarketVolume': 17019,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 7344960,
 'sharesPercentSharesOut': 0.040700004,
 'sharesShort': 298977,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 288721,
 'shortName': 'BioSpecifics Technologies Corp',
 'shortPercentOfFloat': 0.0482,
 'shortRatio': 7.21,
 'startDate': None,
 'state': 'DE',
 'strikePrice': None,
 'symbol': 'BSTC',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 3.339,
 'trailingPE': 18.7062,
 'twoHundredDayAverage': 58.31338,
 'volume': 17019,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.biospecifics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '19803'}